Who is sponsoring NCT02925286?

NCT02925286 is sponsored by Stockholm University.

What drugs are being tested in NCT02925286?

Interventions in NCT02925286: Prevention program for gambling in the workplace.

Is NCT02925286 still recruiting?

NCT02925286 is currently completed. Last updated 27 January 2020.

Last reviewed 2020-01-27 · How we verify

NCT02925286: Alna

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Workplace Prevention Program for Problematic Gambling

Completed NA Last updated 27 January 2020

What this trial tests

NA trial testing Prevention program for gambling in the workplace in Gambling in 5,625 participants. Completed in 30 November 2017.

Timeline

23 August 2016

Primary endpoint
30 November 2017

30 November 2017

Quick facts

Lead sponsor	Stockholm University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	5,625
Start date	23 August 2016
Primary completion	30 November 2017
Estimated completion	30 November 2017

Drugs / interventions tested

Prevention program for gambling in the workplace

Conditions studied

Gambling — all drugs for Gambling →

Sponsor

Stockholm University

Who can join

Adults 18 to 75, any sex, with Gambling. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine the effects of a workplace prevention program targeting problematic gambling.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effects of a workplace prevention programme for problem gambling: study protocol for a cluster randomised controlled trial.
Rafi J, Ivanova E, Rozental A, Carlbring P. · · 2017 · cited 2× · PMID 28951403 · DOI 10.1136/bmjopen-2017-015963

Verify or expand the search:

Other Stockholm University trials

Trials by the same sponsor.

NCT07533812 — AI-Assisted 4-Week Psychodynamic Therapy and Cognitive Behavioral Therapy Via Smartphone for Social Anxiety: A Randomize · NA · active not recruiting
NCT03624400 — Internet-delivered Cognitive Behaviour Therapy for Sleep Problems in ASD · NA · not yet recruiting
NCT06533735 — Parent Web - Support for Families With Young People · NA · recruiting
NCT05172297 — Internet-based Universal Parent Training as a Booster to PATHS®: Parent Web · NA · completed
NCT05598970 — Family and Childhood Development: The Next Generation ('Kizazi Kijacho') · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02925286 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stockholm University
Last refreshed: 27 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02925286.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing